Dendritic cell-based immunotherapy

被引:628
|
作者
Sabado, Rachel L. [1 ]
Balan, Sreekumar [1 ]
Bhardwaj, Nina [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
关键词
dendritic cell; immunotherapy; CERVICAL-CANCER PATIENTS; REGULATORY T-CELLS; INTEGRATED IMMUNE-RESPONSE; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IN-VIVO; SIPULEUCEL-T; LYMPH-NODES; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY;
D O I
10.1038/cr.2016.157
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.
引用
收藏
页码:74 / 95
页数:22
相关论文
共 50 条
  • [21] Dendritic cell-based nanovaccines for cancer immunotherapy
    Paulis, Leonie E.
    Mandal, Subhra
    Kreutz, Martin
    Figdor, Carl G.
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (03) : 389 - 395
  • [22] Dendritic Cell-Based Immunotherapy for Prostate Cancer
    Jaehnisch, Hanka
    Fuessel, Susanne
    Kiessling, Andrea
    Wehner, Rebekka
    Zastrow, Stefan
    Bachmann, Michael
    Rieber, Ernst Peter
    Wirth, Manfred P.
    Schmitz, Marc
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
  • [23] Dendritic cell-based immunotherapy in ovarian cancer
    Coosemans, An
    Vergote, Ignace
    Van Gool, Stefaan W.
    ONCOIMMUNOLOGY, 2013, 2 (12) : 1 - 3
  • [24] Dendritic cell-based immunotherapy for hepatocellular carcinoma
    Morikazu Onji
    Fazle Akbar
    Norio Horiike
    Journal of Gastroenterology, 2001, 36 : 794 - 797
  • [25] Dendritic cell-based immunotherapy of malignant gliomas
    Parajuli, P
    Sloan, AE
    CANCER INVESTIGATION, 2004, 22 (03) : 405 - 416
  • [26] Viral vectors for dendritic cell-based immunotherapy
    Humrich, J
    Jenne, L
    DENDRITIC CELLS AND VIRUS INFECTION, 2003, 276 : 241 - 259
  • [27] Dendritic cell-based immunotherapy for hepatocellular carcinoma
    Onji, M
    Akbar, F
    Horiike, N
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (11) : 794 - 797
  • [28] Dendritic cell-based immunotherapy for myeloid leukemias
    Schuerch, Christian M.
    Riether, Carsten
    Ochsenbein, Adrian F.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [29] Viral vectors for dendritic cell-based immunotherapy
    Jenne, L
    Schuler, G
    Steinkasserer, A
    TRENDS IN IMMUNOLOGY, 2001, 22 (02) : 102 - 107
  • [30] Dendritic cell-based immunotherapy of renal cell carcinoma
    Gitlitz B.J.
    Figlin R.A.
    Pantuck A.J.
    Belldegrun A.S.
    Current Urology Reports, 2001, 2 (1) : 46 - 52